Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. RNA Based Therapeutics Market, by Region, 2018-2027 (USD Billion)
1.2.2. RNA Based Therapeutics Market, by Technology, 2018-2027 (USD Billion)
1.2.3. RNA Based Therapeutics Market, by Application, 2018-2027 (USD Billion)
1.2.4. RNA Based Therapeutics Market, by End-User, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global RNA Based Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global RNA Based Therapeutics Market Dynamics
3.1. RNA Based Therapeutics Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global RNA Based Therapeutics Market Industry Analysis
4.1. Porters 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porters 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global RNA Based Therapeutics Market, by Technology
5.1. Market Snapshot
5.2. Global RNA Based Therapeutics Market by Technology, Performance - Potential Analysis
5.3. Global RNA Based Therapeutics Market Estimates & Forecasts by Technology 2017-2027 (USD Billion)
5.4. RNA Based Therapeutics Market, Sub Segment Analysis
5.4.1. Enabling technologies (such as microarrays, labeling, purification, and others)
5.4.2. Enabled technologies (e.g., RNA Interference (RNAi) technologies and RNA antisense technologies)
Chapter 6. Global RNA Based Therapeutics Market, by Application
6.1. Market Snapshot
6.2. Global RNA Based Therapeutics Market by Application, Performance - Potential Analysis
6.3. Global RNA Based Therapeutics Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
6.4. RNA Based Therapeutics Market, Sub Segment Analysis
6.4.1. Cardiovascular
6.4.2. Kidney Diseases
6.4.3. Oncology
6.4.4. Infectious diseases
6.4.5. Metabolic disorders
6.4.6. Others
Chapter 7. Global RNA Based Therapeutics Market, by End-User
7.1. Market Snapshot
7.2. Global RNA Based Therapeutics Market by End-User - Potential Analysis
7.3. Global RNA Based Therapeutics Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
7.4. RNA Based Therapeutics Market, Sub Segment Analysis
7.4.1. Research
7.4.2. Therapeutics
7.4.3. Diagnosis
Chapter 8. Global RNA Based Therapeutics Market, Regional Analysis
8.1. RNA Based Therapeutics Market, Regional Market Snapshot
8.2. North America RNA Based Therapeutics Market
8.2.1. U.S. RNA Based Therapeutics Market
8.2.1.1. Technology breakdown estimates & forecasts, 2017-2027
8.2.1.2. Application breakdown estimates & forecasts, 2017-2027
8.2.1.3. End-User breakdown estimates & forecasts, 2017-2027
8.2.2. Canada RNA Based Therapeutics Market
8.3. Europe RNA Based Therapeutics Market Snapshot
8.3.1. U.K. RNA Based Therapeutics Market
8.3.2. Germany RNA Based Therapeutics Market
8.3.3. France RNA Based Therapeutics Market
8.3.4. Spain RNA Based Therapeutics Market
8.3.5. Italy RNA Based Therapeutics Market
8.3.6. Rest of Europe RNA Based Therapeutics Market
8.4. Asia-Pacific RNA Based Therapeutics Market Snapshot
8.4.1. China RNA Based Therapeutics Market
8.4.2. India RNA Based Therapeutics Market
8.4.3. Japan RNA Based Therapeutics Market
8.4.4. Australia RNA Based Therapeutics Market
8.4.5. South Korea RNA Based Therapeutics Market
8.4.6. Rest of Asia Pacific RNA Based Therapeutics Market
8.5. Latin America RNA Based Therapeutics Market Snapshot
8.5.1. Brazil RNA Based Therapeutics Market
8.5.2. Mexico RNA Based Therapeutics Market
8.6. Rest of The World RNA Based Therapeutics Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Quark Pharmaceuticals, Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Alnylam Pharmaceuticals, Inc.
9.2.3. Dicerna Pharmaceuticals, Inc.
9.2.4. Tekmira Pharmaceuticals Corp.
9.2.5. Benitec Biopharma Limited
9.2.6. Cenix BioScience GmbH
9.2.7. Genzyme Corporation
9.2.8. Silence Therapeutics PLC
9.2.9. Sirnaomics, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption